Xeris Biopharma to Participate at the Jefferies Healthcare Conference ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: October 2, 2023

Veteran Tech Exec Sissie Hsiao joins Bumble Inc. Board of Directors • iQor Celebrates Customer Service Week 2023 • Feinstein Institutes’ Ross Prize awardees win 2023 Nobel Prize in Physiology or Medicine • Carmen M. Hernández Joins HITN’s Board of Directors • Simon® Earns GRESB Green Star • Andreozzi + Foote File Lawsuits as the New Maryland Child Victims Law Takes Effect • EPA Names Clorox as 2023 Safer Choice Partner of the Year for Advancing Ingredient and Product Safety • BWX Technologies to Announce Third Quarter 2023 Results on Wednesday, November 1 • U.S. Postal Service Commemorates Legacy of Ruth Bader Ginsburg • J&J Patent Move Must be First of Many, says AHF • Essential Utilities Completes Sale of West Virginia Gas Utility Assets • Remedios Varo Exhibition at Art Institute of Chicago Celebrates Hispanic Heritage Through Art • ComplyCube Unveils No-ID Age Estimation to Address Growing Global Age-Restriction Regulations • Empire State Realty Trust Announces Acquisition of Prime Retail Asset in Williamsburg, Brooklyn, as Part of Capital Recycling Pr • Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th • Most Women Skipping Annual Mammograms, According to New MedStar Health Survey • Global Gaming Women Announces Event Line-up at Global Gaming Expo 2023 including the 13th Annual Kick Up Your Heels Fundraiser • Honouliuli National Historic Site Commemorated with Blessing Event and Plaque Dedication Ceremony • How to Make a Difference This Halloween • Link Logistics Publishes Third Annual ESG Report

Xeris Biopharma to Participate at the Jefferies Healthcare Conference

CHICAGO , June 01 /Businesswire/ - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8 at 10:30am Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Xeris’ Investor Relations website at https://xerispharma.com/investor-relations or https://wsw.com/webcast/jeff281/xers/1879020. A replay of the webcast will be available for 60 days.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing differentiated and innovative products across a range of therapies. Xeris has three commercially available products: Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis®, a proven therapy for primary periodic paralysis; and Recorlev® for the treatment of endogenous Cushing’s syndrome. Xeris has a pipeline of development and partnered programs using its formulation sciences, XeriSol™ and XeriJect™, to support long-term product development and commercial success.

Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow Xeris on Twitter, LinkedIn or Instagram.